Immunohistochemical expression of mismatch repair genes (hMSH2 and hMLH1) in hepatocellular carcinoma in Egypt

APMIS

Volumn 118, Issue 12, 2010, Pages 934-940

  Helal, Thanaa E A ^a   Khamis, Nahed S ^a   El Sharkawy, Tarek M ^a   Nada, Ola H ^a   Radwan, Nehal A ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

HCV infection; Hepatocellular carcinoma; Mismatch repair genes

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2;

ADULT; AGED; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EGYPT; FEMALE; GENE EXPRESSION; HEPATITIS C VIRUS; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS CARCINOGENESIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; EGYPT; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS;

EID: 78649499912     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2010.02658.x     Document Type: Article

References (31)

1. Okuda K. Hepatocellular carcinoma. J Hepatol 2000;32:225-37.
2. Tang ZY. Treatment of hepatocellular carcinoma. Digestion 1998;59:556-62.
3. El-Zayadi AR, Badran HM, Barakat EM, Attia ME, Shawky S, Mohamed MK, et al. Hepatocellular carcinoma in Egypt: a single center study over a decade. World J Gastroenterol 2005;11:5193-8.
4. Anwar WA, Khaled HM, Amra HA, EL-Nezami H, Loffredo CA. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention. Mutat Res 2008;659:176-84.
5. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer world wide incidence and trends. Gastroenterology 2004;127:S5-16.
6. Abdel-Wahab M, El-Ghawalby N, Mostafa M, Sultan A, El-Sadany M, Fathy O, et al. Epidemiology of hepatocellular carcinoma in lower Egypt, Mansoura Gastroenterology Center. Hepatogastroenterology 2007;54:157-62.
7. Suriawinata A, Xu R. An update on the molecular genetics of hepatocellular carcinoma. Semin Liver Dis 2004;24:77-88.
8. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002;31:339-46.
9. Feitelson MA, Sun B, Satiroglu Tufan NL, Liu J, Pan J, Lian Z. Genetic mechanisms of hepatocarcinogenesis. Oncogene 2002;21:2593-604.
10. Macdonald GA, Greenson JK, Saito K, Cherian SP, Appelman HD, Boland CR. Microsatellite instability and loss of heterozygosity at DNA mismatch repair gene loci occurs during hepatic carcinogenesis. Hepatology 1998;28:90-7.
11. Yano M, Asahara T, Dohi K, Mizuno T, Iwamoto KS, Seyama T. Close correlation between a p53 or hMSH2 gene mutation in the tumor and survival of hepatocellular carcinoma patients. Int J Oncol 1999;14:447-51.
12. Saeki A, Tamura S, Ito N, Kiso S, Matsuda Y, Yabuuchi I, et al. Lack of frameshift mutations at coding mononucleotide repeats in hepatocellular carcinoma in Japanese patients. Cancer 2000;88:1025-9.
13. Yamamoto H, Itoh F, Fukushima H, Kaneto H, Sasaki S, Ohmura T, et al. Infrequent widespread microsatellite instability in hepatocellular carcinomas. Int J Oncol 2000;16:543-7.
14. Zekri AR, Bahnassi AA, Abdalah S, Saleh M, El-Sherif G, El-Mishad A. Mismatch repair and multidrug resistance genes expression in relation to HCV-associated hepatocellular carcinoma. J Egypt Natl Cancer Inst 2001;13:129-38.
15. Zekri AR, Sabry GM, Bahrassy AA, Shalaby KA, Abdel-Wahab SA, Zakaria S. Mismatch repair genes (hMLH1, hPMS1, hPMS2, GTBP/hMSH6, hMSH2) in the pathogenesis of hepatocellular carcinoma. World J Gastroenterol 2005;11:3020-6.
16. Zhang Y, Yuan F, Presnell SR, Tian K, Gao Y, Tomkinson AE, et al. Reconstitution of a 5'-directed human mismatch repair in a purified system. Cell 2005;122:693-705.
17. Yano M, Hamatani K, Gguchi H, Hiraiy Y, Machphae TG, Sugino K, et al. Prognosis in patients with hepatocellular carcinoma correlates to mutations of p53 and/or hMSH2 genes. Eur J Cancer 2007;43:1092-100.
18. Wang L, Bani-Hani A, Montoya DP, Roche PC, Thibodean SN, Burgant LJ, et al. hMLH1 and hMSH2 expression in human hepatocellular carcinoma. Int J Oncol 2001;19:567-70.
19. Wani Y, Notohara K, Tsukayama C, Okada S. Reduced expression of hMLH1 and hMSH2 gene products in high grade hepatocellular carcinoma. Acta Med Okayama 2001;55:65-71.
20. 6-mathylguanine-DNA methyltransferase and hMLH1 accelerates progression of hepatocellular carcinoma. J Surg Oncol 2003;82:194-200.
21. Matsukura S, Soejima H, Nakagawachi T, Yakushiji H, Ogawa A, Fukuhara M, et al. CPG methylation of MGMT and hMLH1 promoter in hepatocellular carcinoma associated with hepatitis viral infection. Br J Cancer 2003;88:521-9.
22. Hussein MR. Alteration of p53, Bcl-2 and hMSH2 protein expression in the cirrhotic, macroregenerative, dysplastic nodules and hepatocellular carcinoma in upper Egypt. Liver Int 2004;24:552-60.
23. Marcus VA, Madlensky L, Gryfe R, Kim H, So K, Millar A, et al. Immunohistochemistry for hMLH1 and hMSH2. A practical test for DNA mismatch repair deficient tumors. Am J Surg Pathol 1999;23:1248-55.
24. Zekri AR, Sedkey L, El Din HM, Abdel-Aziz AO, Viazov S. The pattern of transmission transfusion virus infection in Egyptian patients. Int J Infect Dis 2002;6:329-31.
25. Hirohashi S, Ishak KG, Kojiro M, Wanless IR, Theise ND, Tsukuma H, et al. Hepatocellular carcinoma. In: Hamilton SR, Aaltonen LA, editors. Pathology & Genetics; Tumors of the Digestive System, World Health Organization Classification of Tumors. Lyon: IARC Press, 2000: 159-72.
26. Hsu SM, Raine L, Frauger H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
27. Liengswangwong U, Karalak A, Morishita Y, Noguchi M, Khuhaprema T, Srivatanakul P, et al. Immunohistochemical expression of mismatch repair genes: a screening tool for predicting mutator phenotype in liver fluke infection-associated intrahepatic cholangiocarcinoma. World J Gastroenterol 2006;12:3740-5.
28. Jin TX, Furihata M, Yamasaki I, Kamada M, Liang SB, Ohtsuki Y, et al. Human mismatch repair gene (hMSH2) product expression in relation to recurrence of transitional cell carcinoma of the urinary bladder. Cancer 1999;85:478-84.
29. Kondo Y, Kanai Y, Sakamoto M, Mizokami M, Ueda R, Hirohashi S, et al. Microsatellite instability associated with hepatocarcinogenesis. J Hepatol 1999;31:529-36.
30. Bock N, Meden H, Regenbrecht M, Junemann B, Wangerin J, Marx D. Expression of the mismatch repair protein hMSH2 in carcinoma in situ and invasive cancer of the breast. Anticancer Res 2000;20:119-24.
31. Muller A, Fishel R. Mismatch repair and the hereditary non polyposis colorectal cancer syndrome. Cancer Invest J 2002;20:102-9.